Company Profile · Healthcare

Huadong Medicine Co Ltd

000963 · Shenzhen

Country: China
IPO date: Dec 22, 1999
Employees: 19,095
Website: www.eastchinapharm.com

Buffett Score

83/100

Elite

Financial snapshot

Market capCN¥48.56B

Revenue (TTM)CN¥44B

EBITDACN¥5B

Profit margin7.86%

ROE13.82%

P/E (TTM)13.98

Forward P/E29.67

PEG0

EPSCN¥1.98

Dividend yield3.46%

52-week rangeCN¥25.29 – CN¥42.30

Data from EODHD, shown in the reporting currency; for reference only, not investment advice.

About the company

Huadong Medicine Co., Ltd, together with its subsidiaries, engages in the wholesale and retail of pharmaceutical products in China and internationally. The company operates through Pharmaceutical Manufacturing, Pharmaceutical Distribution, Medical Aesthetics, and Industrial Microbiology segments. It offers Chinese medicine, immunosuppressive agents, endocrine, digestive system, antineoplastic, cardiovascular, antibiotic drugs, medical beauty field, and medical devices, as well as engages in pharmaceutical logistics and industrial microbiology activities. In addition, the company provides formulation filling, technical, transportation and warehousing services. The company has strategic collaboration with Heidelberg Pharma AG to jointly develop Antibody Drug Conjugates (ADCs). Huadong Medicine Co., Ltd was incorporated in 1993 and is headquartered in Hangzhou, China.

Background

History

Coming soonThis section is being filled in — check back soon.

Industry position

Coming soonThis section is being filled in — check back soon.

Research on this stock

No reports on this stock in your language yet.